This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effective treatment of complex regional pain syndrome: A Synthesis of Findings from 51 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effective treatment of complex regional pain syndrome: A Synthesis of Findings from 51 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major research findings

Complex regional pain syndrome (CRPS) is a severely disabling pain syndrome with no definite established treatment. 32

Exposure in vivo (EXP), a cognitive-behavioral treatment targeting pain-related fear, may be cost-effective for treating CRPS-I compared to pain-contingent physical therapy (PPT). 39

Bisphosphonates may be beneficial in treating CRPS-I patients with bone loss. 9 20

Gabapentin may be effective in treating neuropathic pain associated with CRPS-I. 6

Low-dose naltrexone may be a promising treatment option for patients with CRPS. 42

A combination of intravenous (IV) 20% mannitol and steroid with oral gabapentin is an acceptable and effective treatment for CRPS type 1. 18

Pamidronate may be effective in treating CRPS-I. 5

Low-dose intravenous immunoglobulin treatment (IVIG) may significantly reduce pain from longstanding CRPS. 24 34

Spinal cord stimulation (SCS) has become common international practice for the treatment of CRPS as other therapies fail to provide adequate relief, quality of life, or improvement in function. 31 49

Ketamine, an NMDA receptor antagonist, is a promising treatment for CRPS. 35 16 25 13

Treatment Summary

Treatment options for CRPS are multi-faceted and encompass pharmacotherapy, physical therapy, and neuromodulation. 19

Exposure therapy, a CBT-based approach targeting pain-related fear, may be an effective treatment for CRPS compared to traditional pain-focused physical therapy. 39

Bisphosphonates may be effective in treating CRPS-I. 9 20

Gabapentin may be effective in treating neuropathic pain associated with CRPS-I. 6

Low-dose naltrexone may be a promising treatment option for patients with CRPS. 42

Pamidronate may be effective in treating CRPS-I. 5

Low-dose intravenous immunoglobulin treatment (IVIG) may significantly reduce pain from longstanding CRPS. 24 34

Spinal cord stimulation (SCS) has become common international practice for the treatment of CRPS as other therapies fail to provide adequate relief, quality of life, or improvement in function. 31 49

Ketamine, an NMDA receptor antagonist, is a promising treatment for CRPS. 35 16 25 13

Benefits and Risks

Benefits Summary

Treatment options for CRPS are multi-faceted and encompass pharmacotherapy, physical therapy, and neuromodulation. 19

Exposure therapy, a CBT-based approach targeting pain-related fear, may be an effective treatment for CRPS compared to traditional pain-focused physical therapy. 39

Bisphosphonates may be effective in treating CRPS-I. 9 20

Gabapentin may be effective in treating neuropathic pain associated with CRPS-I. 6

Low-dose naltrexone may be a promising treatment option for patients with CRPS. 42

Pamidronate may be effective in treating CRPS-I. 5

Low-dose intravenous immunoglobulin treatment (IVIG) may significantly reduce pain from longstanding CRPS. 24 34

Spinal cord stimulation (SCS) has become common international practice for the treatment of CRPS as other therapies fail to provide adequate relief, quality of life, or improvement in function. 31 49

Ketamine, an NMDA receptor antagonist, is a promising treatment for CRPS. 35 16 25 13

Risks Summary

Treatment options for CRPS are multi-faceted and encompass pharmacotherapy, physical therapy, and neuromodulation. 19

Exposure therapy, a CBT-based approach targeting pain-related fear, may be an effective treatment for CRPS compared to traditional pain-focused physical therapy. 39

Bisphosphonates may be effective in treating CRPS-I. 9 20

Gabapentin may be effective in treating neuropathic pain associated with CRPS-I. 6

Low-dose naltrexone may be a promising treatment option for patients with CRPS. 42

Pamidronate may be effective in treating CRPS-I. 5

Low-dose intravenous immunoglobulin treatment (IVIG) may significantly reduce pain from longstanding CRPS. 24 34

Spinal cord stimulation (SCS) has become common international practice for the treatment of CRPS as other therapies fail to provide adequate relief, quality of life, or improvement in function. 31 49

Ketamine, an NMDA receptor antagonist, is a promising treatment for CRPS. 35 16 25 13

Comparison of Studies

Similarities

Many studies agree that treatment approaches for CRPS are multifaceted, combining pharmacological, physical, and neuromodulation methods. 19

Differences

The efficacy of specific treatments for CRPS and their effectiveness vary across studies. For instance, some studies find bisphosphonates beneficial, while others demonstrate limited efficacy. 9 20

Consistency and Contradictions in Results

Research on CRPS treatments doesn't always yield consistent findings. For example, the effectiveness of bisphosphonates varies across different studies. 9 20

CRPS treatment can be highly individualized, and finding an effective treatment might involve trying multiple approaches. 19

Considerations for Practical Application

CRPS treatment can be highly individualized, and finding an effective treatment might involve trying multiple approaches. 19

Consultation and treatment under the guidance of a qualified healthcare professional is crucial for managing CRPS. 19

Limitations of Current Research

Research on CRPS treatments is still inadequate, particularly in the area of large-scale randomized controlled trials. 19

Future Research Directions

To establish effective treatments for CRPS, further research, including larger randomized controlled trials, is needed. 19

Research into the underlying mechanisms of CRPS and the development of personalized treatment approaches are also critical. 19

Conclusion

CRPS is a debilitating pain disorder with no definitive established treatment. Research is ongoing to find effective treatments, but currently, there is no one-size-fits-all solution. 32

Consult with a healthcare professional for diagnosis and management of CRPS. 19

Further research into CRPS mechanisms and personalized treatment approaches holds great promise for improving the lives of those affected by this complex condition. 19

Treatment List

Exposure therapy

Bisphosphonates

Gabapentin

Low-dose naltrexone

Pamidronate

Low-dose intravenous immunoglobulin treatment (IVIG)

Spinal cord stimulation (SCS)

Ketamine

Dorsal root ganglion stimulation (DRGS)

Local lidocaine injections

Oral citalopram

Prednisolone


Keywords
Benefit Keywords
Risk Keywords
Literature analysis of 51 papers
Positive Content
47
Neutral Content
0
Negative Content
4
Article Type
25
10
24
18
50

Language : German


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : Serbian


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.